DNA restriction fragment analysis of the proopiomelanocortin gene in schizophrenia and bipolar disorders.
The method of DNA restriction fragment analysis using gene probes for the proopiomelanocortin (POMC) gene was employed to detect possible molecular variation in the POMC gene in schizophrenia and bipolar illness. No gross structural abnormalities in restriction fragments were observed with the set of restriction enzymes used. Two allelic restriction sites were observed giving rise to fragment length polymorphisms. One of these is a new polymorphism, not previously reported, which will be of value as a linkage marker. The associations between the two DNA polymorphisms that are closely linked to the POMC gene and both schizophrenia and bipolar disorder were investigated. No association was found, thus adding weight to the evidence that there are no alterations in the POMC gene in schizophrenia and bipolar illness.
Feder
J
J
Gurling
H M
HM
Darby
J
J
Cavalli-Sforza
L L
LL
D001483:Base Sequence; D001714:Bipolar Disorder / Q000235:genetics*; D002874:Chromosome Mapping; D004262:DNA Restriction Enzymes; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic; D011333:Pro-Opiomelanocortin / Q000235:genetics*; D012559:Schizophrenia / Q000235:genetics*
D011333:Pro-Opiomelanocortin; D004262:DNA Restriction Enzymes